(2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile, 98%, 10g

(3,5-Dichloropyridin-2-yl)methanamine, 95+%, 500mg

Ethyl ferulate, 98%, 500g

(3aR,3'aR,8aS,8'aS)-2,2'-Ethylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 97%, 100mg

Indoline-2-carboxylic acid, 95.0%, 100g

4-Bromo-3-chloro-2-iodoaniline, 98.0%, 5g

2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethanesulfonate potassium, 95.0%, 1g

DBD-CO-Hz [=4-(N,N-Dimethylaminosulfonyl)-7-(N-hydrazinocarbonylmethyl-N-methyl)amino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

N,N-diethylglycine hydrochloride, 95.0%, 10g

MOGUISTEINE, 97%, 250mg

(2,3-Dichloro-4-formylphenyl)boronic acid, 97%, 1g

3,5-dibromo-1H-pyrazole, 10g

1-Phenylcyclohexanol, 95.0%, 100g